Clinical Potential of Extracellular Vesicles in Type 2 Diabetes
Type 2 diabetes (T2D) is a major public health disease which is increased in incidence and prevalence throughout the whole world. Insulin resistance (IR) in peripheral tissues and insufficient pancreatic β-cell mass and function have been recognized as primary mechanisms in the pathogenesis of T2D,...
Main Authors: | , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-01-01
|
Series: | Frontiers in Endocrinology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fendo.2020.596811/full |
id |
doaj-f72509879d294751afbd1893f68c2e65 |
---|---|
record_format |
Article |
spelling |
doaj-f72509879d294751afbd1893f68c2e652021-01-21T09:37:04ZengFrontiers Media S.A.Frontiers in Endocrinology1664-23922021-01-011110.3389/fendo.2020.596811596811Clinical Potential of Extracellular Vesicles in Type 2 DiabetesJie Liu0Jie Liu1Jie Liu2Xin Sun3Xin Sun4Fu-Liang Zhang5Fu-Liang Zhang6Hang Jin7Hang Jin8Xiu-Li Yan9Shuo Huang10Shuo Huang11Shuo Huang12Zhen-Ni Guo13Zhen-Ni Guo14Zhen-Ni Guo15Yi Yang16Yi Yang17Yi Yang18Stroke Center & Clinical Trial and Research Center for Stroke, Department of Neurology, The First Hospital of Jilin University, Changchun, ChinaChina National Comprehensive Stroke Center, Changchun, ChinaJilin Provincial Key Laboratory of Cerebrovascular Disease, Changchun, ChinaStroke Center & Clinical Trial and Research Center for Stroke, Department of Neurology, The First Hospital of Jilin University, Changchun, ChinaChina National Comprehensive Stroke Center, Changchun, ChinaStroke Center & Clinical Trial and Research Center for Stroke, Department of Neurology, The First Hospital of Jilin University, Changchun, ChinaChina National Comprehensive Stroke Center, Changchun, ChinaStroke Center & Clinical Trial and Research Center for Stroke, Department of Neurology, The First Hospital of Jilin University, Changchun, ChinaChina National Comprehensive Stroke Center, Changchun, ChinaStroke Center & Clinical Trial and Research Center for Stroke, Department of Neurology, The First Hospital of Jilin University, Changchun, ChinaStroke Center & Clinical Trial and Research Center for Stroke, Department of Neurology, The First Hospital of Jilin University, Changchun, ChinaChina National Comprehensive Stroke Center, Changchun, ChinaJilin Provincial Key Laboratory of Cerebrovascular Disease, Changchun, ChinaStroke Center & Clinical Trial and Research Center for Stroke, Department of Neurology, The First Hospital of Jilin University, Changchun, ChinaChina National Comprehensive Stroke Center, Changchun, ChinaJilin Provincial Key Laboratory of Cerebrovascular Disease, Changchun, ChinaStroke Center & Clinical Trial and Research Center for Stroke, Department of Neurology, The First Hospital of Jilin University, Changchun, ChinaChina National Comprehensive Stroke Center, Changchun, ChinaJilin Provincial Key Laboratory of Cerebrovascular Disease, Changchun, ChinaType 2 diabetes (T2D) is a major public health disease which is increased in incidence and prevalence throughout the whole world. Insulin resistance (IR) in peripheral tissues and insufficient pancreatic β-cell mass and function have been recognized as primary mechanisms in the pathogenesis of T2D, while recently, systemic chronic inflammation resulting from obesity and a sedentary lifestyle has also gained considerable attention in T2D progression. Nowadays, accumulating evidence has revealed extracellular vesicles (EVs) as critical mediators promoting the pathogenesis of T2D. They can also be used in the diagnosis and treatment of T2D and its complications. In this review, we briefly introduce the basic concepts of EVs and their potential roles in the pathogenesis of T2D. Then, we discuss their diagnostic and therapeutic potentials in T2D and its complications, hoping to open new prospects for the management of T2D.https://www.frontiersin.org/articles/10.3389/fendo.2020.596811/fulltype 2 diabetesextracellular vesiclesmechanismdiagnosistreatment |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Jie Liu Jie Liu Jie Liu Xin Sun Xin Sun Fu-Liang Zhang Fu-Liang Zhang Hang Jin Hang Jin Xiu-Li Yan Shuo Huang Shuo Huang Shuo Huang Zhen-Ni Guo Zhen-Ni Guo Zhen-Ni Guo Yi Yang Yi Yang Yi Yang |
spellingShingle |
Jie Liu Jie Liu Jie Liu Xin Sun Xin Sun Fu-Liang Zhang Fu-Liang Zhang Hang Jin Hang Jin Xiu-Li Yan Shuo Huang Shuo Huang Shuo Huang Zhen-Ni Guo Zhen-Ni Guo Zhen-Ni Guo Yi Yang Yi Yang Yi Yang Clinical Potential of Extracellular Vesicles in Type 2 Diabetes Frontiers in Endocrinology type 2 diabetes extracellular vesicles mechanism diagnosis treatment |
author_facet |
Jie Liu Jie Liu Jie Liu Xin Sun Xin Sun Fu-Liang Zhang Fu-Liang Zhang Hang Jin Hang Jin Xiu-Li Yan Shuo Huang Shuo Huang Shuo Huang Zhen-Ni Guo Zhen-Ni Guo Zhen-Ni Guo Yi Yang Yi Yang Yi Yang |
author_sort |
Jie Liu |
title |
Clinical Potential of Extracellular Vesicles in Type 2 Diabetes |
title_short |
Clinical Potential of Extracellular Vesicles in Type 2 Diabetes |
title_full |
Clinical Potential of Extracellular Vesicles in Type 2 Diabetes |
title_fullStr |
Clinical Potential of Extracellular Vesicles in Type 2 Diabetes |
title_full_unstemmed |
Clinical Potential of Extracellular Vesicles in Type 2 Diabetes |
title_sort |
clinical potential of extracellular vesicles in type 2 diabetes |
publisher |
Frontiers Media S.A. |
series |
Frontiers in Endocrinology |
issn |
1664-2392 |
publishDate |
2021-01-01 |
description |
Type 2 diabetes (T2D) is a major public health disease which is increased in incidence and prevalence throughout the whole world. Insulin resistance (IR) in peripheral tissues and insufficient pancreatic β-cell mass and function have been recognized as primary mechanisms in the pathogenesis of T2D, while recently, systemic chronic inflammation resulting from obesity and a sedentary lifestyle has also gained considerable attention in T2D progression. Nowadays, accumulating evidence has revealed extracellular vesicles (EVs) as critical mediators promoting the pathogenesis of T2D. They can also be used in the diagnosis and treatment of T2D and its complications. In this review, we briefly introduce the basic concepts of EVs and their potential roles in the pathogenesis of T2D. Then, we discuss their diagnostic and therapeutic potentials in T2D and its complications, hoping to open new prospects for the management of T2D. |
topic |
type 2 diabetes extracellular vesicles mechanism diagnosis treatment |
url |
https://www.frontiersin.org/articles/10.3389/fendo.2020.596811/full |
work_keys_str_mv |
AT jieliu clinicalpotentialofextracellularvesiclesintype2diabetes AT jieliu clinicalpotentialofextracellularvesiclesintype2diabetes AT jieliu clinicalpotentialofextracellularvesiclesintype2diabetes AT xinsun clinicalpotentialofextracellularvesiclesintype2diabetes AT xinsun clinicalpotentialofextracellularvesiclesintype2diabetes AT fuliangzhang clinicalpotentialofextracellularvesiclesintype2diabetes AT fuliangzhang clinicalpotentialofextracellularvesiclesintype2diabetes AT hangjin clinicalpotentialofextracellularvesiclesintype2diabetes AT hangjin clinicalpotentialofextracellularvesiclesintype2diabetes AT xiuliyan clinicalpotentialofextracellularvesiclesintype2diabetes AT shuohuang clinicalpotentialofextracellularvesiclesintype2diabetes AT shuohuang clinicalpotentialofextracellularvesiclesintype2diabetes AT shuohuang clinicalpotentialofextracellularvesiclesintype2diabetes AT zhenniguo clinicalpotentialofextracellularvesiclesintype2diabetes AT zhenniguo clinicalpotentialofextracellularvesiclesintype2diabetes AT zhenniguo clinicalpotentialofextracellularvesiclesintype2diabetes AT yiyang clinicalpotentialofextracellularvesiclesintype2diabetes AT yiyang clinicalpotentialofextracellularvesiclesintype2diabetes AT yiyang clinicalpotentialofextracellularvesiclesintype2diabetes |
_version_ |
1724330088010350592 |